ETS-1 Transcription Factor Binds Cooperatively to the Palindromic Head to Head ETS-binding Sites of the Stromelysin-1 Promoter by Counteracting Autoinhibition*
暂无分享,去创建一个
Marc Aumercier | M. Aumercier | D. Stéhelin | David Baillat | D. Baillat | Agnès Bègue | Dominique Stéhelin | A. Bègue
[1] B. Graves,et al. Phosphorylation represses Ets-1 DNA binding by reinforcing autoinhibition. , 2000, Genes & development.
[2] B. Wasylyk,et al. The c‐Ets oncoprotein activates the stromelysin promoter through the same elements as several non‐nuclear oncoproteins. , 1991, The EMBO journal.
[3] A. Ivanoff,et al. Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines , 2001, International journal of cancer.
[4] M Tilley,et al. A simple modification of Blum's silver stain method allows for 30 minute detection of proteins in polyacrylamide gels. , 1994, Journal of biochemical and biophysical methods.
[5] R. Kodandapani,et al. New Insights on DNA Recognition by ets Proteins from the Crystal Structure of the PU.1 ETS Domain-DNA Complex* , 1996, The Journal of Biological Chemistry.
[6] A. Seth,et al. Ets transcription factors and targets in osteogenesis , 2000, Oncogene.
[7] T. Noumi,et al. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. , 1995, Oncogene.
[8] B. Graves,et al. Specificity within the ets family of transcription factors. , 1998, Advances in cancer research.
[9] T. Gu,et al. Auto-Inhibition of Ets-1 Is Counteracted by DNA Binding Cooperativity with Core-Binding Factor α2 , 2000, Molecular and Cellular Biology.
[10] M. Rivera,et al. A Role for CREB Binding Protein and p300 Transcriptional Coactivators in Ets-1 Transactivation Functions , 1998, Molecular and Cellular Biology.
[11] T. Graf,et al. Mutual activation of Ets‐1 and AML1 DNA binding by direct interaction of their autoinhibitory domains , 1999, The EMBO journal.
[12] B. Vandenbunder,et al. The Ets family contains transcriptional activators and repressors involved in angiogenesis. , 2001, The international journal of biochemistry & cell biology.
[13] Thiennu H. Vu,et al. Matrix metalloproteinases: effectors of development and normal physiology. , 2000, Genes & development.
[14] T. Kodadek,et al. Chemistry for the analysis of protein-protein interactions: rapid and efficient cross-linking triggered by long wavelength light. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Graf,et al. Cooperative interaction of Ets‐1 with USF‐1 required for HIV‐1 enhancer activity in T cells , 1998, The EMBO journal.
[16] D. Pinkel,et al. The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis , 1999, Cell.
[17] M. Kurkinen,et al. A polyomavirus enhancer A-binding protein-3 site and Ets-2 protein have a major role in the 12-O-tetradecanoylphorbol-13-acetate response of the human stromelysin gene. , 1993, The Journal of biological chemistry.
[18] T. Johansen,et al. The Nuclear Factor SPBP Contains Different Functional Domains and Stimulates the Activity of Various Transcriptional Activators* , 2000, The Journal of Biological Chemistry.
[19] D. Stéhelin,et al. Erg, an Ets-family member, differentially regulates human collagenase1 (MMP1) and stromelysin1 (MMP3) gene expression by physically interacting with the Fos/Jun complex. , 1996, Oncogene.
[20] A. Henney,et al. Human stromelysin gene promoter activity is modulated by transcription factor ZBP‐89 , 1999, FEBS letters.
[21] F. Bartel,et al. Mouse models in the study of the Ets family of transcription factors , 2000, Oncogene.
[22] M. Razzaque,et al. Renal expression of the Ets-1 proto-oncogene during progression of rat crescentic glomerulonephritis. , 2000, Journal of the American Society of Nephrology : JASN.
[23] B. Fingleton,et al. The PEA3 Subfamily of Ets Transcription Factors Synergizes with β-Catenin–LEF-1 To Activate Matrilysin Transcription in Intestinal Tumors , 2001, Molecular and Cellular Biology.
[24] R. Marmorstein,et al. Structures of SAP-1 bound to DNA targets from the E74 and c-fos promoters: insights into DNA sequence discrimination by Ets proteins. , 1998, Molecular cell.
[25] T. Gu,et al. Auto-Inhibition and Partner Proteins, Core-Binding Factor β (CBFβ) and Ets-1, Modulate DNA Binding by CBFα2 (AML1) , 2000, Molecular and Cellular Biology.
[26] S. Zucker,et al. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment , 2000, Oncogene.
[27] M. Gröger,et al. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha. , 2001, Arthritis and rheumatism.
[28] M. Abe,et al. ETS‐1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin β3 , 1999, Journal of cellular physiology.
[29] A. Mauviel. Cytokine regulation of metalloproteinase gene expression , 1993, Journal of cellular biochemistry.
[30] B. Graves,et al. Characterization of the cooperative function of inhibitory sequences in Ets-1 , 1996, Molecular and cellular biology.
[31] J. Ghysdael,et al. Calcium-induced phosphorylation of ETS1 inhibits its specific DNA binding activity. , 1994, The Journal of biological chemistry.
[32] T. Hattori,et al. Selective distribution of matrix metalloproteinase-3 (MMP-3) in Alzheimer’s disease brain , 2000, Acta Neuropathologica.
[33] A. Seth,et al. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody. , 1993, Oncogene.
[34] L. McIntosh,et al. Inhibitory Module of Ets-1 Allosterically Regulates DNA Binding through a Dipole-facilitated Phosphate Contact* , 2002, The Journal of Biological Chemistry.
[35] A. Sharrocks,et al. The ETS-domain transcription factor family. , 1997, Nature reviews. Molecular cell biology.
[36] J. Erickson,et al. Real‐time DNA binding measurements of the ETSl recombinant oncoproteins reveal significant kinetic differences between the p42 and p51 isoforms , 1994, Protein science : a publication of the Protein Society.
[37] D. Stéhelin,et al. The Ets Transcription Factors Interact with Each Other and with the c-Fos/c-Jun Complex via Distinct Protein Domains in a DNA-dependent and -independent Manner* , 1997, The Journal of Biological Chemistry.
[38] B. Fingleton,et al. Matrix metalloproteinases: biologic activity and clinical implications. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] M. Gillespie,et al. Autoinhibition as a transcriptional regulatory mechanism. , 1998, Cold Spring Harbor symposia on quantitative biology.
[40] B. Wasylyk,et al. Sp100 Interacts with ETS-1 and Stimulates Its Transcriptional Activity , 2002, Molecular and Cellular Biology.
[41] B. Vandenbunder,et al. Stromal expression of c-Ets1 transcription factor correlates with tumor invasion. , 1994, Cancer research.
[42] L. McIntosh,et al. Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets‐1 , 1996, Protein science : a publication of the Protein Society.
[43] E. Hay,et al. Guidebook to the extracellular matrix and adhesion proteins , 1995 .
[44] B. Erman,et al. Transcriptional Activation by ETS and Leucine Zipper-Containing Basic Helix-Loop-Helix Proteins , 1999, Molecular and Cellular Biology.
[45] Ioanna G Maroulakou,et al. Expression and function of Ets transcription factors in mammalian development: a regulatory network , 2000, Oncogene.
[46] A. Seth,et al. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. , 1996, Oncogene.
[47] J. Lautenberger,et al. Interaction of ETS-1 and ERGB/FLI-1 proteins with DNA is modulated by spacing between multiple binding sites as well as phosphorylation. , 1996, Oncogene.
[48] M. Lark,et al. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. , 1992, The Journal of biological chemistry.
[49] L. Matrisian,et al. TEL, a Putative Tumor Suppressor, Modulates Cell Growth and Cell Morphology of Ras-Transformed Cells While Repressing the Transcription of stromelysin-1 , 2000, Molecular and Cellular Biology.
[50] S. Ho,et al. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. , 1989, Gene.
[51] T. Graf,et al. DNA binding by c‐Ets‐1, but not v‐Ets, is repressed by an intramolecular mechanism. , 1992, The EMBO journal.
[52] H. Yokota,et al. Messenger-RNA expression of matrix metalloproteinases, tissue inhibitors of metalloproteinases, and transcription factors in rheumatic synovial cells under mechanical stimuli. , 2001, Bone.
[53] S. Weitzman,et al. p300/cAMP-responsive Element-binding Protein Interactions with Ets-1 and Ets-2 in the Transcriptional Activation of the Human Stromelysin Promoter* , 1999, The Journal of Biological Chemistry.
[54] Z. Werb,et al. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter , 2000, Oncogene.
[55] C. Garvie,et al. Structural studies of Ets-1/Pax5 complex formation on DNA. , 2001, Molecular cell.
[56] N. Bhat,et al. Human ETS1 oncoprotein. Purification, isoforms, -SH modification, and DNA sequence-specific binding. , 1992, The Journal of biological chemistry.